Diseases, Conditions, Syndromes

Vaccine for hepatitis C inches closer to reality

(HealthDay)—An initial study suggests that a potential vaccine against hepatitis C, a liver disease that affects at least 130 million people worldwide, is safe in people.

Diseases, Conditions, Syndromes

For inmates, pricey hepatitis C drug could make financial sense

New, significantly improved hepatitis C drugs have revolutionized how the disease is treated, but they are also expensive. One such drug, sofosbuvir, costs more than $7,000 a week for 12 weeks of treatment.

Diseases, Conditions, Syndromes

Rats of New York and the diseases they carry

In the first study to look at would-be diseases carried by New York City rats, scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health identified bacterial pathogens, including ...

Medications

US approves pricey new pill against hepatitis C

US regulators on Friday approved Harvoni, a daily pill to treat hepatitis C that is simpler to administer than long-standing treatments but that carries a steep price tag.

Diseases, Conditions, Syndromes

Study says hepatitis C will be a rare disease by about 2036

Hepatitis C, a major infectious disease in the United States with 180 million cases worldwide, will likely become a rare disease by about 2036, according to a University of Pittsburgh Graduate School of Public Health analysis.

Diseases, Conditions, Syndromes

$1,000 Sovaldi now hepatitis treatment of choice

(AP)—A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.

Diseases, Conditions, Syndromes

Hepatitis C cured in co-infected HIV patients

A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.

page 19 from 36